Michael R. Zalutsky

Clinical Experience with α-Particle–Emitting ²¹¹At: Treatment of Recurrent Brain Tumor Patients with ²¹¹At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

Michael R. Zalutsky, David A. Reardon, Gamal Akabani et al. · Journal of Nuclear Medicine · 2007 · 396 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Peter A. Humphrey, Albert J. Wong, Bert Vogelstein et al. · Proceedings of the National Academy of Sciences · 1990 · 383 citations

Medicine, Molecular Biology, Oncology +17

Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT

R.J. Jaszczak, Jianying Li, Huili Wang et al. · Physics in Medicine and Biology · 1994 · 312 citations

Engineering, Biomedical Engineering, Nuclear Medicine +9

A Plasmonic Gold Nanostar Theranostic Probe for <i>In Vivo</i> Tumor Imaging and Photothermal Therapy

Yang Liu, Jeffrey R. Ashton, Everett J. Moding et al. · Theranostics · 2015 · 300 citations · Full text

Medicine, Biomedical Engineering, Oncology +17

Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

John H. Sampson, Gamal Akabani, Gary E. Archer et al. · Journal of Neuro-Oncology · 2003 · 239 citations

Medicine, Neuroscience, Oncology +8